Add to ORKGObjectives: Cytokeratin-18 is an intermediate filament that could be a candidate cell death marker in monitoring chemotherapy efficiency. The aim of this study was to evaluate cell death determination effectiveness of CK18 ELISA assay in HCT-116 colon cancer cells treated with clinical compatible dosages of FOLFIRI chemotherapy combination
of death among patients with CRC is metastasis that can occur in regional lymph nodes3 or via blood ...
Adjuvant therapy in colorectal cancer has evolved to become the standard of care, whereas the tumor ...
Background: CK18 is an epithelial-specific cytokeratin that undergoes cleavage by caspases during ap...
Objectives: Cytokeratin-18 is an intermediate filament that could be a candidate cell death marker i...
BackgroundTumor cell death generates products that can be measured in the circulation of cancer pati...
Abstract Background Tumor cell death generates products that can be measured in the circulation of c...
BACKGROUND: Plasma biomarkers may be particularly useful as a predictor or early marker of clinical ...
AbstractCirculating full-length and caspase-cleaved cytokeratin 18 (CK18) are considered biomarkers ...
Circulating full-length and caspase-cleaved cytokeratin 18 (CK18) are considered biomarkers of chemo...
WOS: 000366737700005Cytokeratin 18 (CK18) is the major component of intermediate filaments in epithe...
Objectives: In cervical cancer, increased cytokeratin 18 (CK18) filament expression is associated wi...
Bu çalışmadaæ Folfox kemoterapi protokolü uygulanan kolorektal kanser hastalarının tedavisi sırasın...
Cytokeratin 20 (CK20) is a well-established marker for colon epithelium. Herein, we suggest that CK2...
Cytokeratins, biochemically related to intermediate filaments (IF), form an intracellular network of...
The primary aim of this study was to compare measurement of apoptosis by M30 immunoreactivity (a bio...
of death among patients with CRC is metastasis that can occur in regional lymph nodes3 or via blood ...
Adjuvant therapy in colorectal cancer has evolved to become the standard of care, whereas the tumor ...
Background: CK18 is an epithelial-specific cytokeratin that undergoes cleavage by caspases during ap...
Objectives: Cytokeratin-18 is an intermediate filament that could be a candidate cell death marker i...
BackgroundTumor cell death generates products that can be measured in the circulation of cancer pati...
Abstract Background Tumor cell death generates products that can be measured in the circulation of c...
BACKGROUND: Plasma biomarkers may be particularly useful as a predictor or early marker of clinical ...
AbstractCirculating full-length and caspase-cleaved cytokeratin 18 (CK18) are considered biomarkers ...
Circulating full-length and caspase-cleaved cytokeratin 18 (CK18) are considered biomarkers of chemo...
WOS: 000366737700005Cytokeratin 18 (CK18) is the major component of intermediate filaments in epithe...
Objectives: In cervical cancer, increased cytokeratin 18 (CK18) filament expression is associated wi...
Bu çalışmadaæ Folfox kemoterapi protokolü uygulanan kolorektal kanser hastalarının tedavisi sırasın...
Cytokeratin 20 (CK20) is a well-established marker for colon epithelium. Herein, we suggest that CK2...
Cytokeratins, biochemically related to intermediate filaments (IF), form an intracellular network of...
The primary aim of this study was to compare measurement of apoptosis by M30 immunoreactivity (a bio...
of death among patients with CRC is metastasis that can occur in regional lymph nodes3 or via blood ...
Adjuvant therapy in colorectal cancer has evolved to become the standard of care, whereas the tumor ...
Background: CK18 is an epithelial-specific cytokeratin that undergoes cleavage by caspases during ap...